Mochi Health
Mochi Health is a telehealth startup founded in 2022 by Dr. Myra Ahmad, MD, a UCSF-trained obesity medicine physician. The platform focuses exclusively on weight management, offering both compounded and brand-name GLP-1 medications through a subscription membership model. Mochi pairs medication prescriptions with access to board-certified obesity medicine providers and registered dietitians — a level of clinical specialization that most budget telehealth platforms skip.
Overview
- Consultation Model
- Hybrid
- Headquarters
- San Francisco, CA
- Shipping
- 3-5 business days
- Lab Testing
- No
- Prescriber Info
- Licensed healthcare providers evaluate patients and prescribe based on clinical eligibility.
- Founded
- 2022
Pros
- Video consultations with board-certified obesity medicine providers
- Registered dietitian access included in membership
- Orforglipron (oral GLP-1) available at $149/mo
- Brand-name injectable GLP-1s available through insurance, plus non-GLP-1 alternatives
- Insurance support with prior authorization handling
- Available in 49 states
Cons
- Membership fee is required on top of medication cost
- Lab work not included (recommended but at additional cost)
- Some patients have reported shipping delays
- Early-stage company with limited funding (~$1M raised) compared to established players
- Compounded GLP-1 options permanently unavailable
- Not available in Alabama
Pricing
| Medication | Dose | Price | Billing |
|---|---|---|---|
| semaglutide | 0.25-2.4mg/week | $178 | monthly |
| tirzepatide | 2.5-15mg/week | $278 | monthly |